Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: J Allergy Clin Immunol. 2021 Mar 10;147(6):2009–2020. doi: 10.1016/j.jaci.2021.02.037

TABLE I.

Steps in asthma therapy during pregnancy

Step Preferred controller medication Alternative controller medication
1 None
2 Low-dose ICS LTRA, theophylline, or cromolyn
3 Medium-dose ICS or low-dose ICS plus LABA Low-dose ICS plus LTRA or theophylline
4 Medium-dose ICS plus LABA Medium-dose ICS plus either LTRA or theophylline
5 High-dose ICS plus LABA Medium-dose ICS plus LABA plus tiotropium; consider adding omalizumab for patients with allergy or adding other asthma biologics (anti–IL-5, anti–IL-5Rα, anti–IL-4Rα) for appropriate candidates
6 High-dose ICS plus LABA plus oral prednisone Consider adding omalizumab for patients with allergy or adding other asthma biologics (anti–IL-5, anti–IL-5Rα, anti–IL-4Rα) for appropriate candidates

ICS, Inhaled corticosteroid; LABA, long-acting β-agonist; LTRA, leukotriene receptor antagonist.

There are no randomized clinical trials of asthma biologics that intentionally included pregnant women.

Data modified from Schatz and Dombrowski.13